Malaria is a life-threatening infectious disease caused by the Plasmodium parasite, primarily transmitted to humans through the bites of infected female Anopheles mosquitoes. With symptoms ranging from fever, chills, and headache to more severe complications such as anemia, organ failure, and even death, malaria poses a significant global health burden, particularly in tropical and subtropical regions. Plasmodium falciparum is the most lethal species, responsible for the majority of malaria-related deaths. Prompt and effective treatment with antimalarial medications is essential for recovery, while preventive measures such as bed nets, insecticide spraying, and antimalarial prophylaxis play crucial roles in controlling the spread of the disease. Vaccination efforts, like the introduction of the RTS,S/AS01 malaria vaccine, aim to provide additional tools in the fight against malaria.

Malaria manifests with a spectrum of symptoms, typically beginning with fever, chills, and flu-like malaise. These initial signs may be followed by recurrent episodes of fever, accompanied by sweating and profound fatigue. Other common symptoms include headaches, muscle aches, and nausea. In severe cases, malaria can lead to complications such as anemia, respiratory distress, and organ failure, particularly with the involvement of the Plasmodium falciparum species.

Malaria is primarily transmitted to humans through the bites of infected female Anopheles mosquitoes. These mosquitoes carry the Plasmodium parasite, which multiplies in the mosquito's gut and salivary glands. When an infected mosquito bites a person, it injects sporozoites into the bloodstream. The sporozoites then travel to the liver, where they mature and reproduce. After leaving the liver, the parasites enter the bloodstream, infect red blood cells, and initiate the symptomatic phase of the disease. Malaria transmission can occur year-round in tropical and subtropical regions, but it is often more prevalent during the rainy season when mosquito breeding sites increase.

The diagnosis of malaria involves a combination of clinical evaluation and laboratory testing. Clinical symptoms, such as fever, chills, and headache, may lead to suspicion of malaria, especially in individuals with a history of travel to endemic areas. Laboratory tests, such as microscopic examination of blood smears or rapid diagnostic tests (RDTs) detecting specific malaria antigens, confirm the presence of the Plasmodium parasite. Molecular techniques like polymerase chain reaction (PCR) may be used for further confirmation and species identification.

Malaria prevention strategies encompass a multi-faceted approach aimed at reducing mosquito exposure and controlling the spread of the Plasmodium parasite. Key preventive measures include the use of insecticide-treated bed nets, indoor residual spraying to target mosquitoes resting indoors, and antimalarial medications for chemoprophylaxis in individuals residing in or traveling to malaria-endemic regions. Additionally, community-based interventions, such as environmental management to eliminate mosquito breeding sites, contribute to overall control efforts. Malaria vaccines, like the RTS,S/AS01 vaccine, have also been developed to provide an additional layer of protection.

Malaria treatment involves the administration of antimalarial medications to eliminate the Plasmodium parasite from the bloodstream. The choice of medication depends on the specific Plasmodium species causing the infection and the severity of symptoms. Artemisinin-based combination therapies (ACTs) are commonly recommended as first-line treatments for uncomplicated malaria, offering a highly effective and rapid reduction of parasite levels. Severe cases, especially those caused by Plasmodium falciparum, may require intravenous administration of artesunate, followed by a full course of ACT. Resistance to antimalarial drugs is a concern, highlighting the importance of accurate diagnosis and appropriate treatment.

  • Malaria is preventable and treatable with measures like bed nets, medications, and timely antimalarial treatment.

  • Malaria is the third most fatal communicable disease among children aged one month to five years, after pneumonia and diarrhea.

  • Long-lasting insecticide-treated bed nets can protect two people for three years from malaria transmission.


Select your destination to book your travel vaccination.

Find Destination